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Purpose or Objective: The standard treatment regimen of 
patients with primary glioblastoma multiforme (PGBM) 
consists of neurosurgery, radio- and chemotherapy. Despite 
this multimodal treatment the overall survival of patients 
with PGBM is still approximately 15 months.  
The stress-inducible heat shock protein 70 (Hsp70) 
contributes to tumor cell survival and is associated with poor 
prognosis, metastasis and therapy resistance. Therefore, the 
aim of this study is to analyze Hsp70 in PGBM tumor samples 
as a future prognostic biomarker and possible therapy target. 
 
Material and Methods: Formalin fixed paraffin embedded 
(FFPE) sections of 44 human PGBM patients (isocitrate 
dehydrogenase wildtype) were analyzed by 
immunohistochemistry for Hsp70 (cmHsp70.1, IgG1, 
multimmune GmbH, Munich, Germany). Taking the intensity 
of Hsp70 staining into account, quantitative expression 
analysis of tumor cells with stained cytoplasm was 
performed. Two categories of Hsp70 staining were defined: 
Up to 40% and more than 40% positive tumor cells within the 
tumor regions. The Hsp70 immunoreactivity was correlated 
with the survival of the patients using the Cox regression 
analysis. 
 
Results: Preliminary data show that the median survival of 
PGBM patients can be predicted by the Hsp70 
immunoreactivity of the tumor cells. Regression analysis 
showed that patients with Hsp70 expression of more than 40% 
have a higher risk of disease progression with a hazard ratio 
of 2.59 (p= 0.045). 
 
 
 
Hsp70 expression in FFPE IHC section (Hsp70 positive tumor 
cells are brown) 
 
Conclusion: These data provide the first evidence that Hsp70 
expression in FFPE sections of PGBM patients is associated 
with disease progression. Moreover, measuring Hsp70 in FFPE 
sections of PGBM patients before radiotherapy treatment may 
be used as biomarker for the success of the therapy. The 
independency of Hsp70 expression and O6-methylguanin-DNA 
methyltransferase (MGMT) is currently under investigation. 
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Purpose or Objective: In recent years, it has been suggested 
that wound drainage fluids (WDF) of patients operated for 
head and neck squamous cell carcinoma (HNSCC) may be 
characterized by molecular biomarkers with potential 
prognostic and predictive value. The detection of adverse 
features in the early perioperative setting could possibly lead 
to a refinement of current adjuvant treatments in high-risk 
patients. The purpose of our study is to report on the 
feasibility and preliminary results of a pilot prospective study 
on WDF analysis in HNSCC. 
 
Material and Methods: 14 consecutive surgically resected 
HNSCCs were studied. WDF were collected 1 day and 3 days 
after surgery from the cancer operative bed (COB). In 5 
patients, WDF was collected also from free flap donor site 
(FFDS). WDF were centrifuged for 15 min at 3500 rpm, then 
divided in aliquots and stored at -80°C until analysis. The aim 
of the present study was to evaluate the expression of factors 
involved in tumor growth and progression 1 day and 3 days 
after surgery. EGF, VEGF, SDF-1 and osteopontin levels were 
measured in WDF using commercially available enzyme-linked 
immunosorbent assay (ELISA) kits. Each sample was analyzed 
in duplicates and then averaged for a mean value. Quality 
control pools of low, normal, or high concentrations for all 
parameters were included in each assay. The obtained results 
were expressed as pg/ml (EGF, VEGF, SDF-1 ) or ng/ml 
(osteopontin).  
 
Results: A mean of 67 ml of WDF from COB and 51 ml from 
FFDS at day 1, and 42 ml from COB and 20 ml from FFDS at 
day 3 were collected for each patient. EGF expression was 
significantly reduced from day 1 to day 3 after surgery both 
in COB (140.7±10.55 vs. 45.12±13.35 pg/ml, p<0.001) and in 
FFDS (157.1±4.08 vs. 95.59±32.89 pg/ml, p<0.05). VEGF 
expression increased from 1 to 3 day both in COB 
(1277.74±64.54 vs. 1616.81±151.4 pg/ml, p<0.05) and in FFDS 
(1227.51±19.39 vs. 1400.25±77.66 pg/ml, p<0.05). The 
expression of markers of invasiveness and metastasis 
increased from day 1 to day 3: osteopontin expression 
significantly increased from day 1 to day 3 both in COB 
(9.97±0.68 vs. 16.87±0.56 ng/ml, p<0.001) and in FFDS 
(9.51±1.23 vs. 15.83±1.08 ng/ml, p<0.01). SDF-1 expression 
increased from day 1 to day 3 in COB (646.8±65.39 vs. 
1084.22±148.8 pg/ml, p<0.05). No differences in SDF-1 
expression were detected in FFDS. 
 
Conclusion: Preliminary data from pilot study evidenced that 
microenvironment induced by surgery favors residual tumor 
cell proliferation and progression. Growth factor expression is 
higher early after surgery (24 hours); on the contrary, 
expression of markers of invasiveness and metastasis 
increases from day 1 to day 3 after surgery. The few samples 
of WDF from FFDS do not allow to evidence differences of 
biomarkers expression between COB and FFDS. 
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Purpose or Objective: Hematologic toxicity and in particular 
decrease in the peripheral blood leukocyte and lymphocyte 
count is an important side effect of pelvic radiation therapy. 
The aim of this study was to investigate the kinetic of the 
redistribution of circulating leukocytes after pelvic 
irradiation in a animal model with in vivo non-invasive 
imaging modality. 
